A Visible Codelivery Nanovaccine of Antigen and Adjuvant with Self-Carrier for Cancer Immunotherapy-Reference-Cited by-同舟云学术

A Visible Codelivery Nanovaccine of Antigen and Adjuvant with Self-Carrier for Cancer Immunotherapy

Published:2019-01-10 Issue:5 Volume:11 Page:4876-4888
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Dong Xia¹,Liang Jie¹,Yang Afeng¹,Qian Zhiyong²^ORCID,Kong Deling¹^ORCID,Lv Feng^ORCID

Affiliation:

1. Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, PR China

2. State Key Laboratory of Biotherapy, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu 610041, Sichuan, PR China

Funder

Natural Science Foundation of Tianjin City

Chinese Academy of Medical Sciences

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.8b20364

Reference46 articles.

1. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion